Literature DB >> 27497911

Plasma MicroRNA-126-5p is Associated with the Complexity and Severity of Coronary Artery Disease in Patients with Stable Angina Pectoris.

Hai-Yu Li1, Xin Zhao, Yu-Zhou Liu, Zhe Meng, Dan Wang, Fan Yang, Qiang-Wei Shi.   

Abstract

BACKGROUND: Coronary artery disease (CAD) is a major problem worldwide. As an endothelium-enriched microRNA (miRNA), miR-126 has been reported to serve as a potential biomarker of acute myocardial infarction. However, the relationship between miR-126 and the severity of CAD remains unknown. This study was designed to test whether circulating miR-126 levels are associated with the severity of CAD.
METHODS: The present study enrolled 40 patients who had risk factors for CAD without angiographically significant CAD, and 110 patients presenting with stable angina pectoris, who were validated left main coronary artery disease (LMCA) and/or multi-vessel disease by coronary angiography. The expression levels of plasma miR-126-5p from all enrolled subjects were estimated by quantitative real-time polymerase chain reaction (qRT-PCR). Then, the relationships between plasma miR-126-5p levels, number of diseased vessels and the corresponding Synergy between PCI with Taxus and Cardiac surgery (SYNTAX) score were analyzed.
RESULTS: The expression of circulating miR-126-5p was affected by some CAD risk factors including aging, dyslipidemia and DM. Furthermore, plasma miR-126-5p levels were significantly down-regulated in CAD patients with multi-vessel disease, higher SYNTAX score, rather than isolated LMCA and low SYNTAX score.
CONCLUSION: Circulating miR-126-5p has emerged as a potential biomarker for complexity and severity of CAD in patients with stable angina pectoris.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27497911     DOI: 10.1159/000447794

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  26 in total

Review 1.  An integrated approach to coronary heart disease diagnosis and clinical management.

Authors:  Teresa Infante; Ernesto Forte; Concetta Schiano; Carlo Cavaliere; Carlo Tedeschi; Andrea Soricelli; Marco Salvatore; Claudio Napoli
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 2.  Pathophysiology of cardiovascular disease in diabetes mellitus.

Authors:  Gerardo Rodriguez-Araujo; Hironori Nakagami
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-02-14

3.  Plasma circulating microRNAs in patients with stable coronary artery disease - Impact of different cardiovascular risk profiles and glomerular filtration rates.

Authors:  Karlis Trusinskis; Maris Lapsovs; Sandra Paeglite; Evija Knoka; Laima Caunite; Mairita Mazule; Ieva Briede; Sanda Jegere; Indulis Kumsars; Inga Narbute; Ilze Konrade; Andrejs Erglis; Aivars Lejnieks
Journal:  J Clin Transl Res       Date:  2021-04-16

Review 4.  An Analysis of Mechanisms for Cellular Uptake of miRNAs to Enhance Drug Delivery and Efficacy in Cancer Chemoresistance.

Authors:  Justine M Grixti; Duncan Ayers; Philip J R Day
Journal:  Noncoding RNA       Date:  2021-04-16

5.  The association between pre-miR-27a rs895819 polymorphism and myocardial infarction risk in a Chinese Han population.

Authors:  Meng-Yun Cai; Jie Cheng; Meng-Yuan Zhou; Li-Li Liang; Si-Min Lian; Xiao-Shan Xie; Shun Xu; Xinguang Liu; Xing-Dong Xiong
Journal:  Lipids Health Dis       Date:  2018-01-06       Impact factor: 3.876

6.  Mechanism of modulation through PI3K-AKT pathway about Nepeta cataria L.'s extract in non-small cell lung cancer.

Authors:  Jiaxin Fan; Yongrui Bao; Xiansheng Meng; Shuai Wang; Tianjiao Li; Xin Chang; Guanlin Yang; Tao Bo
Journal:  Oncotarget       Date:  2017-05-09

7.  Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway.

Authors:  Hanbing Shi; Hongxia Bi; Xingyuan Sun; Haiying Dong; Yunfei Jiang; Haijun Mu; Guohua Liu; Weili Kong; Ruizhi Gao; Jiang Su
Journal:  Mol Med Rep       Date:  2018-01-18       Impact factor: 2.952

8.  Effect of various Danshen injections on patients with coronary heart disease after percutaneous coronary intervention: A protocol for a systematic review and network meta-analysis.

Authors:  Zehao Zhu; Yuanping Wang; Weilin Liao; Huimin Li; Dawei Wang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

9.  SLC35E3 identified as a target of novel‑m1061‑5p via microRNA profiling of patients with cardiovascular disease.

Authors:  Feng Gao; Fa-Gang Wang; Ren-Rong Lyu; Feng Xue; Jian Zhang; Ran Huo
Journal:  Mol Med Rep       Date:  2018-01-25       Impact factor: 2.952

Review 10.  Endothelial Cell Aging: How miRNAs Contribute?

Authors:  Munekazu Yamakuchi; Teruto Hashiguchi
Journal:  J Clin Med       Date:  2018-07-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.